Psychiatry Research
Volume 121, Issue 2 , Pages 123-132 , 1 December 2003

Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity

  • Pinkhas Sirota

      Affiliations

    • Y. Abarbanel Mental Health Center, 15 Keren Kayemet Street, Bat Yam 59100, Israel
    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972-3-5552700; fax: +972-3-5552706
    • ,
  • Ronit Gavrieli

      Affiliations

    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Department of Pediatrics, Laboratory for Leukocyte Functions, Meir General Hospital, Sapir Medical Center, Kfar Saba, Israel
    • ,
  • Baruch Wolach

      Affiliations

    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Department of Pediatrics, Laboratory for Leukocyte Functions, Meir General Hospital, Sapir Medical Center, Kfar Saba, Israel

Received 9 August 2002 ,Revised 14 July 2003 ,Accepted 20 August 2003.

References 

  1. Altamura AC, Boin F, Maes M. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. European Neuropsychopharmacology. 1999;10:1–4
  2. American Psychiatric Association, 1994. Diagnostic and Statistical Manual for Mental Disorders. Author, Washington, DC
  3. Arvindakshan M, Sitasawad S, Debsikar V, Ghate M, Evans D, Horrobin DF, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry. 2003;53:56–64
  4. Arolt V, Rothermundt M, Wandinger KP, Kirchner H. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Molecular Psychiatry. 2000;5:150–158
  5. Babior BM. The respiratory burst of phagocytes. Journal of Clinical Investigation. 1984;73:599–601
  6. Biffl WL, Moore EE, Moore FA, Carle VS, Kim FJ, Franciose RJ. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Archives of Surgery. 1994;129:1131–1136
  7. Biffl WL, Moore EE, Moore FA, Barnett CC, Carl VS, Peterson VN. Interleukin-6 delays neutrophil apoptosis. Archives of Surgery. 1996;131:24–29
  8. Boxer LA. Neutrophil disorders: qualitative abnormalities of the neutrophil. In:  Williams WJ,  Beutler E,  Erslev AJ,  Lichtman MA editor. Hematology. Fifth ed. New York: McGraw-Hill; 1995;
  9. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation. 1963;21(Suppl. 97):77
  10. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clinical Immunology. 2001;99:7–17
  11. Cadet JL. Free radical mechanisms in the central nervous system: an overview. International Journal of Neuroscience. 1988;40:13–18
  12. Clawson CC, Repline JE. Quantitation of maximal bactericidal capacity in human neutrophils. Journal of Laboratory and Clinical Medicine. 1976;88:316–327
  13. Cosentino M, Fietta A, Caldiroli E, Marino F, Rispoli L, Cornelli M, et al. Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. Progress in Neuro-psychopharmacology and Biological Psychiatry. 1996;20:1117–1129
  14. Drath DB, Karnovsky MI. Superoxide production by phagocytic leukocytes. Journal of Experimental Medicine. 1975;141:257–261
  15. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 1978;35:837–844
  16. Falk W, Goodwin RH, Leonard EJ. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. Journal of Immunology Methods. 1980;33:239
  17. Firer M, Sirota P, Schild K, Elizur A, Slor H. Anticardiolipin antibodies are elevated in drug free multiply affected families with schizophrenia. Journal of Clinical Immunology. 1994;14:73–78
  18. Frommberger UH, Bauer J, Haselbauer P, Frailin A, Riemann D, Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: a comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neuroscience. 1997;247:228–233
  19. Ganguli R, Yang Z, Shurin G, Changappa KN, Brar JS, Gubbi AV, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Research. 1994;51:1–10
  20. Horrobin DF, Manku MS, Morse-Fisher N, Vaddadi KS, Courtney P, Glen AI, et al. Essential fatty acids in plasma phospholipids in schizophrenia. Biological Psychiatry. 1989;25:562–568
  21. Katanaev VL. Signal transduction in neutrophil chemotaxis. Biochemistry (Moscow). 2001;46:351–368
  22. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261
  23. Kramer VHP, Grimberger JA, Timmerman H, Bast A. The effects of ischemia and recirculation, hypoxia and recovery on antioxidant factors and β-adrenoreceptor density: is the damage in erythrocytes a reflection of brain damage caused by complete cerebral ischemia and by hypoxia?. Biochemical Research Communications. 1987;149:568–575
  24. Leon JD. Smoking and vulnerability for schizophrenia. Schizophrenia Bulletin. 1996;22:405–409
  25. Lin A, Kenis G, Bingotti S, Tura GJ, De Jong R, Bosmans E, et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophrenia Research. 1998;32:9
  26. Lohr JB. Oxygen radicals and neuropsychiatric illness, some speculations. Archives of General Psychiatry. 1991;48:1097–1106
  27. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. Journal of Psychiatric Research. 1995;29:141–152
  28. Maes M, Delange J, Ranjan R, Meltzer HY, Demyder R, Cooremans W, et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Research. 1997;66:1–11
  29. Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophrenia Research. 1996;19:1–17
  30. Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1996;55:45–54
  31. Mahadik SP, Mulchandani M, Hedge MV, Ranjekar PK. Cultural and socioeconomic differences in dietary intake of essential fatty acids and antioxidants: effects on the outcome. In:  Horrobin D,  Glen AL,  Peet M editor. Phospholipid Spectrum Psychiatric Disorders. Carnforth, UK: Marius Press; 1999;p. 167–179
  32. Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry. 2001;25:463–493
  33. McAdams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry. 1993;17:971–984
  34. Melamed Y, Sirota P, Dicker DR, Fishman P. Superoxide anion production by neutrophils derived from peripheral blood of schizophrenic patients. Psychiatry Research. 1998;77:29–34
  35. Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H. Impaired antioxidant defense at the onset of psychosis. Schizophrenia Research. 1996;19:19–26
  36. Müller N, Reidel M, Ackenheil M, Schwarz MJ. The role of immune function in schizophrenia: an overview. European Archives of Psychiatry and Clinical Neuroscience. 1999;249:62–68
  37. Naudin J, Mege JL, Azorin JM, Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophrenia Research. 1996;20:269–273
  38. Peet M, Langharne JD, Mellor J, Ramchand CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients and the clinical effects of dietary supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1996;55:71–75
  39. Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM. Elevated levels of soluble interleukin 2 receptors in schizophrenia. Archives of Genetic Psychiatry. 1989;46:291–292
  40. Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1996;55:33–43
  41. Reeves EP, Lu H, Jacobs HL, Messina CGM, Bolsover S, Gabella G, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416:291–297
  42. Richardson JS. Free radicals in the genesis of Alzheimer's disease. Annals of the New York Academy of Sciences. 1993;695:73–76
  43. Rwegellera GG, Fernando KH, Okongo'o O. Bactericidal activity of neutrophils of schizophrenic patients. Medical Journal of Zambia. 1982;16:21–22
  44. Schattner A, Cori Y, Hahn T, Sirota P. No evidence for autoimmunity in schizophrenia. Journal of Autoimmunity. 1996;9:661–666
  45. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000;79:170–200
  46. Sethi S, Singh MP, Dikshit M. Nitric oxide-mediated augmentation of polymorphonuclear free radical generation after hypoxia-reoxygenation. Blood. 1999;93:333–340
  47. Shintani F, Kanba S, Mauro N, Nakaki T, Nibuga M, Suzuki E, et al. Serum interleukin-6 in schizophrenic patients. Life Sciences. 1991;49:661–664
  48. Sinet PM. Metabolism of oxygen derivatives in Down's Syndrome. Annals of the New York Academy of Sciences. 1982;396:83–94
  49. Sirota P. Is schizophrenia an autoimmune disease?. Israel Journal of Medical Science. 1990;26:694–697
  50. Sirota P, Firer M, Schild K, Barak Y, Zurgil N, Elizur A, et al. Increased anti-sm antibodies in schizophrenic patients and their families. Progress in Neuro-psychopharmacology and Biological Psychiatry. 1993;17:793–800
  51. Sirota P, Firer M, Schild K, Tanay A, Elizur A, Meytes D, et al. Autoantibodies to DNA in multicase families with schizophrenia. Biological Psychiatry. 1993;33:450–455
  52. Sirota P, Schild K, Elizur A, Djaldetti M, Fishman P. Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Progress in Neuro-psychopharmacology and Biological Psychiatry. 1995;19:75–83
  53. Sirota P, Mosheva T, Reznik I, Elizur A, Hochman A. Altered antioxidant status in schizophrenia and the beneficial effect of vitamin E (Abstract). Biological Psychiatry. 1999;45(Supplement):43S
  54. Smith RS. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Medical Hypotheses. 1992;39:248–257
  55. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, et al. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology (Berlin). 2001;158:140–145
  56. Stefanis CN, Issidrides MR. Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment. Biological Psychiatry. 1976;11:53–68
  57. Suzuki Y, Leherer RI. NADPH oxidase activity in human neutrophils stimulated by phorbol myristate acetate. Journal of Clinical Investigation. 1980;66:1049–1418
  58. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC. Human granulocyte macrophage colony-stimulating factor is a neutrophil activator. Nature. 1985;314:361–363
  59. Wolach B, Bachner RL, Boxer LA. Review: clinical and laboratory approach to the management of neutrophil dysfunction. Israel Journal of Medical Science. 1982;18:897–916
  60. Wolach B, Ben Dor M, Chomsky O, Gavrieli R, Shinitzky M. Improved chemotactic ability of neonatal polymorphonuclear cells induced by mild membrane rigidification. Journal of Leukocyte Biology. 1992;51:324–328
  61. Wolach B, Sonnenschein D, Gavrieli R, Chomsky O, Pomeranz A, Yuli I. Neonatal neutrophil inflammatory responses: parallel studies of light scattering, cell polarization, chemotaxis, superoxide release, and bactericidal activity. American Journal of Hematology. 1998;58:8–15
  62. Wolach B, Gavrieli R, Pomeranz A. Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions. Pediatric Research. 2000;48:369–373
  63. Wong CT, Tsoi WF, Saha N. Acute phase proteins in male Chinese schizophrenic patients in Singapore. Schizophrenia Research. 1996;22:165–171
  64. Yao JK, Reddy R, McElhinny LG, van Kammen DP. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research. 1998;32:1–8
  65. Zhelev DV, Alteraifi A. Signaling in the motility responses of the human neutrophil. Annals of Biomedical Engineering. 2002;30:356–370

PII: S0165-1781(03)00222-1

doi: 10.1016/S0165-1781(03)00222-1

Psychiatry Research
Volume 121, Issue 2 , Pages 123-132 , 1 December 2003

Article Tools

* Image Usage & Resolution